Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Learn which accounts to rebalance first for tax efficiency. A simple framework helps you sequence moves to minimize taxes over time.
25,802 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Myro (MYRO) faces a high-volatility path as traders eye 2025 to 2030 targets. This report lays out the price scenario...
A Supreme Court ruling curbs the president’s tariff powers under IEEPA, easing uncertainty for manufacturers. A CFO w...
Six AI-driven forecasts clash with Standard Chartered’s trimmed XRP target, spotlighting how ETF dynamics and policy ...
As geopolitical risk stays elevated, investors are reevaluating defense allocations. Lessons from WWII’s most feared ...
A high-potential niche in energy could unlock life-changing gains. Learn why small modular reactors and NuScale Power...
The BEA's second estimate shows Q4 GDP growth at 0.7%, down from the initial 1.4% reading. The revision signals a slo...
In a rapid 48-hour sprint, Congress advanced major child safety bills on both sides of the Capitol, signaling a new e...
Oil and currency markets tremble as new Iran-related tensions top the global agenda. Asia, with its export-led growth...
Goldman Sachs sets COIN target at $235, signaling renewed confidence in Coinbase as crypto markets stabilize and inst...
Everus ECG's 2026 earnings story hinges on growing recurring revenue and cash flow turnarounds. This analysis breaks ...
A wave of generative AI tools is upending Microsoft’s per-seat Office model. With Copilot seats climbing and pricing ...